With Synlab AG, a new stock will be continuously tradable on the international market segment global market from 30 April 2021. According to its own statements the company, headquartered in Munich (Germany), is the largest European clinical laboratory and medical diagnostic services provider. Tomorrow, the company’s stock exchange debut will take place in Frankfurt. Immediately after the first pricing on Deutsche Börse, the new shares will also be available on the international market segment of the Vienna Stock Exchange.
The global market offers domestic investors a broad selection of more than 730 international shares from 26 countries. Austrian investors can trade on their national stock exchange at domestic fees and during local trading hours. As market makers, Baader Bank and Lang & Schwarz ensure additional liquidity and attractive prices.